chr1-171331769-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002022.3(FMO4):c.614G>A(p.Arg205Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000861 in 1,613,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002022.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMO4 | NM_002022.3 | c.614G>A | p.Arg205Gln | missense_variant | 6/10 | ENST00000367749.4 | NP_002013.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMO4 | ENST00000367749.4 | c.614G>A | p.Arg205Gln | missense_variant | 6/10 | 1 | NM_002022.3 | ENSP00000356723.3 | ||
FMO4 | ENST00000462992.1 | n.380G>A | non_coding_transcript_exon_variant | 3/4 | 3 | |||||
FMO4 | ENST00000475780.5 | n.652-5587G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 249918Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135188
GnomAD4 exome AF: 0.0000931 AC: 136AN: 1461530Hom.: 0 Cov.: 31 AF XY: 0.0000743 AC XY: 54AN XY: 727078
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.614G>A (p.R205Q) alteration is located in exon 6 (coding exon 4) of the FMO4 gene. This alteration results from a G to A substitution at nucleotide position 614, causing the arginine (R) at amino acid position 205 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at